4.1 Article

Secondary skin involvement in classic Hodgkin lymphoma: Results of an international collaborative cutaneous lymphoma working group study of 25 patients

Journal

JOURNAL OF CUTANEOUS PATHOLOGY
Volume 48, Issue 11, Pages 1367-1378

Publisher

WILEY
DOI: 10.1111/cup.14077

Keywords

cutaneous lymphoma; Hodgkin lymphoma; skin involvement

Ask authors/readers for more resources

Cutaneous involvement by classic Hodgkin lymphoma (CHL) is extremely rare, with only 25 cases identified between 1990 and 2020 in this comprehensive study. Most cases were examples of systemic CHL with secondary skin dissemination, with the majority of patients diagnosed with stage IV disease at first diagnosis. The interval between initial diagnosis of HL and development of skin lesions ranged from 6 to 108 months.
Background Cutaneous involvement by classic Hodgkin lymphoma (CHL) is an extraordinarily rare phenomenon in the current era. To date, no single large case series of cutaneous involvement by Hodgkin lymphoma has ever been reported in the literature. Methods A comprehensive search for cases designated skin and Hodgkin was performed at different institutions between 1990 and 2020. Twenty-five cases were identified, and each case was independently reviewed by at least three board-certified dermatopathologists and/or hematopathologists. Results All cases represented examples of systemic CHL with secondary skin dissemination. A single lesion, usually a tumor, nodule or infiltrative plaque was observed in 56% of cases and multiple lesions were present in 28% of cases. Most patients (86%-12/14) had a diagnosis of stage IV disease at first diagnosis. The interval between the clinical (first) diagnosis of HL and the development of skin lesions ranged between 6 and 108 months (average 33.75 months). Comprehensive histopathologic evaluation of these cases (at the initial diagnosis) revealed a diagnosis of classic HL not otherwise specified (NOS) in 60% of cases (15/25), nodular sclerosis type in 24% (6/25), mixed cellularity in 12% (3/25), and lymphocyte depleted in 4% (1/25). Conclusions We provide documentation of a large series of CHL with secondary skin involvement in association with CHL with additional clinical, morphologic, and immunophenotypic features.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Dermatology

Histopathologic and molecular characterization of BAP-1-inactivated melanoma

Elisabeth M. Miller, Konstantinos Linos, Carlos E. Bacchi, Alejandro A. Gru, Shyam S. Raghavan

Summary: This study describes the histopathologic and molecular characterization of five cases of BAP-1-inactivated cutaneous malignant melanomas. The cases were confirmed as malignant melanoma based on cytomorphology, immunohistochemistry, and molecular testing. All cases showed malignant copy number alterations.

JOURNAL OF CUTANEOUS PATHOLOGY (2023)

Article Dermatology

A novel case of cutaneous myxoid spindle cell neoplasm with FMR1-ALK gene fusion and CD34/S100 co-expression

Israel Kasago, Umut Aypar, Purvil Sukhadia, Chad Vanderbilt, Marc Ladanyi, Tierra Hurd, Melissa Pulitzer

Summary: A new subtype of superficial CD34 (+) and S100 (+) cutaneous spindle cell neoplasm, with ALK rearrangements, has been recently described. This tumor is characterized by bland spindled cells organized in whorls and cords against myxoid stroma and is known as superficial ALK-rearranged myxoid spindle cell neoplasm. We report a case of a 78-year-old male with a 3-mm pink papule on the chest, initially suspected as cutaneous carcinoma. Histopathological examination revealed a biphasic tumor with CD34 (+), S100 (+), and D5F3-ALK expression, and ALK-rearrangement was confirmed using fluorescence in situ hybridization and RNA sequencing.

JOURNAL OF CUTANEOUS PATHOLOGY (2023)

Article Pathology

Malignant undifferentiated and rhabdoid tumors of the gastroesophageal junction and esophagus with SMARCA4 loss: a case series

Srishti Gupta, Sean W. Noona, Stefan E. Pambuccian, Brian Robinson, Linda W. Martin, Eli Williams, Edward B. Stelow, Shyam S. Raghavan

Summary: Undifferentiated SMARCA4-deficient carcinoma of the esophagus and gastroesophageal junction is a rare and highly aggressive malignancy. This case series presents high-grade undifferentiated malignant neoplasms with SMARCA4 loss and a rhabdoid phenotype. The study identifies common immunoreactivity and genetic abnormalities in these cases.

HUMAN PATHOLOGY (2023)

Article Pathology

Diagnostic Accuracy of GATA6 Immunostaining in Sebaceous Tumors of the Skin

Benedicte Oules, Lydia Deschamps, Pierre Sohier, Matthieu Tihy, Anais Chassac, Anais Couvelard, Eric Frouin, Maxime Battistella

Summary: GATA6 immunostaining has been identified as a new diagnostic tool for sebaceous tumors, showing higher accuracy compared to other markers and being able to differentiate from non-sebaceous tumors. It also shows similar sensitivity to adipophilin and higher specificity, especially in clear-cell histology. Furthermore, GATA6 expression is found in skin metastases of gastrointestinal origin but not in metastases from breast or lung cancers.

MODERN PATHOLOGY (2023)

Article Oncology

Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas

E. Toulemonde, S. Chevret, M. Battistella, E. M. Neidhardt, C. Nardin, F. Le Du, N. Meyer, M. Veron, L. Gambotti, A. Lamrani-Ghaouti, P. Jamme, C. Chaffaut, M. De Pontville, E. Saada-Bouzid, M. Beylot-Barry, C. Simon, T. Jouary, A. Marabelle, L. Mortier

Summary: Trichoblastic carcinoma is a rare malignant cutaneous adnexal tumor. There is currently no consensus on the treatment of this cancer. A study evaluated the efficacy of Nivolumab in patients with Trichoblastic carcinoma, and found that it showed promising results with a good control of the disease. Further studies are needed to confirm these findings and determine the role of Nivolumab in the treatment of Trichoblastic carcinoma.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

Article Cell & Tissue Engineering

Systematic dissection of coordinated stromal remodeling identifies Sox10+ glial cells as a therapeutic target in myelofibrosis

Shawn M. Sarkaria, Junsong Zhou, Suying Bao, Wenqi Zhao, Yinshan Fang, Jianwen Que, Govind Bhagat, Chaolin Zhang, Lei Ding

Summary: Remodeling of the bone marrow microenvironment is observed in primary myelofibrosis (PMF), characterized by expansion of collagen-expressing myofibroblasts derived from LepR+ mesenchymal cells and upregulation of arteriolar-signature genes in endothelial cells. Unbiased single-cell RNA sequencing confirmed the origin of myofibroblasts and revealed reduced expression of hematopoietic niche factors and increased expression of fibrogenic factors. Expansion of pericytes and Sox10+ glial cells and enhanced cell-cell signaling suggest their functional roles in PMF. Targeting bone marrow glial cells could ameliorate fibrosis and improve pathology in PMF.

CELL STEM CELL (2023)

Article Computer Science, Interdisciplinary Applications

Automated analysis of small intestinal lamina propria to distinguish normal, Celiac Disease, and Non-Celiac Duodenitis biopsy images

Oliver Faust, Simona De Michele, Joel E. W. Koh, V Jahmunah, Oh Shu Lih, Aditya P. Kamath, Prabal Datta Barua, Edward J. Ciaccio, Suzanne K. Lewis, Peter H. Green, Govind Bhagat, U. Rajendra Acharya

Summary: This study aimed to utilize AI models to distinguish between normal individuals, individuals with celiac disease (CD), and individuals with non-celiac duodenitis (NCD) based on characteristics of the small intestinal lamina propria. By preprocessing high magnification biopsy images, the study found that AI models can effectively differentiate between different types of intestinal disorders and can potentially be applied in clinical settings.

COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2023)

Letter Dermatology

Periorbital erythema and oedema revealing angioimmunoblastic T cell lymphoma

Donatienne De Clippele, Laure Frumholtz, Marie-Dominique Vignon-Pennamen, Thierry Molina, Hannah Moatti, Maxime Battistella, Marlene Ochmann, Caroline Ram-Wolff, Antoine Petit, Martine Bagot, Adele De Masson

EUROPEAN JOURNAL OF DERMATOLOGY (2023)

Letter Oncology

Whole exome sequencing of primary cutaneous CD4+small/medium T-cell lymphoproliferative disorders

Craig R. Soderquist, Susan Hsiao, Jiuhong Pang, Alejandro A. Gru, Sameera Husain, Bachir Alobeid, Govind Bhagat

HEMATOLOGICAL ONCOLOGY (2023)

Article Engineering, Biomedical

Polyacrylamide-based hydrogel coatings improve biocompatibility of implanted pump devices

Doreen Chan, Caitlin L. Maikawa, Andrea I. d'Aquino, Shyam S. Raghavan, Megan L. Troxell, Eric A. Appel

Summary: Researchers developed a novel material for coating subcutaneously implanted devices to reduce foreign body responses and local tissue inflammation. The material showed improved biocompatibility compared to standard materials in mouse models, and was also effective in improving the function and lifespan of insulin pumps in a rat model of diabetes.

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2023)

Article Multidisciplinary Sciences

KMT2D acetylation by CREBBP reveals a cooperative functional interaction at enhancers in normal and malignant germinal center B cells

Sofija Vlasevska, Laura Garcia-Ibanez, Romain Duval, Antony B. Holmes, Rahat Jahan, Bowen Cai, Andrew Kim, Tongwei Mo, Katia Basso, Rajesh K. Soni, Govind Bhagat, Riccardo Dalla-Favera, Laura Pasqualucci

Summary: Heterozygous inactivating mutations of KMT2D and CREBBP are common in B cell lymphoma, and they co-occur in a significant number of follicular lymphoma and EZB/C3 diffuse large B cell lymphoma cases. The combination of haploinsufficiency of Crebbp and Kmt2d promotes the expansion of abnormally polarized germinal centers, which is an early event in lymphoma development. These findings highlight the functional and biochemical interaction between Crebbp and Kmt2d, and its implications for the treatment of lymphomas with enhancer defects induced by their combined loss.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Correction Oncology

The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (vol 36, pg 1720, 2022)

Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D. Attygalle, Iguaracyra Barreto de Oliveira Araujo, Emilio Berti, Govind Bhagat, Anita Maria Borges, Daniel Boyer, Mariarita Calaminici, Amy Chadburn, John K. C. Chan, Wah Cheuk, Wee-Joo Chng, John K. Choi, Shih-Sung Chuang, Sarah E. Coupland, Magdalena Czader, Sandeep S. Dave, Daphne de Jong, Arianna Di Napoli, Ming-Qing Du, Kojo S. Elenitoba-Johnson, Judith Ferry, Julia Geyer, Dita Gratzinger, Joan Guitart, Sumeet Gujral, Marian Harris, Christine J. Harrison, Sylvia Hartmann, Andreas Hochhaus, Patty M. Jansen, Kennosuke Karube, Werner Kempf, Joseph Khoury, Hiroshi Kimura, Wolfram Klapper, Alexandra E. Kovach, Shaji Kumar, Alexander J. Lazar, Stefano Lazzi, Lorenzo Leoncini, Nelson Leung, Vasiliki Leventaki, Xiao-Qiu Li, Megan S. Lim, Wei-Ping Liu, Abner Louissaint, Andrea Marcogliese, L. Jeffrey Medeiros, Michael Michal, Roberto N. Miranda, Christina Mitteldorf, Santiago Montes-Moreno, William Morice, Valentina Nardi, Kikkeri N. Naresh, Yasodha Natkunam, Siok-Bian Ng, Ilske Oschlies, German Ott, Marie Parrens, Melissa Pulitzer, S. Vincent Rajkumar, Andrew C. Rawstron, Karen Rech, Andreas Rosenwald, Jonathan Said, Clementine Sarkozy, Shahin Sayed, Caner Saygin, Anna Schuh, William Sewell, Reiner Siebert, Aliyah R. Sohani, Ritsuro Suzuki, Reuben Tooze, Alexandra Traverse-Glehen, Francisco Vega, Beatrice Vergier, Ashutosh D. Wechalekar, Brent Wood, Luc Xerri, Wenbin Xiao, Norah Olubunmi Akinola, Yassmine Akkari, Luis M. Allende, Katsuyuki Aozasa, Iguaracyra Araujo, Luca Arcaini, Kirit M. Ardeshna, Naoko Asano, Andishe Attarbaschi, Chris M. Bacon, Sharon Louise Barrans, Tracy Batchelor, Maxime Battistella, Linda B. Baughn, Amir Behdad, Sigbjorn Berentsen, Giada Bianchi, Jacob Bledsoe, Peter Borchmann, Mark Bower, Barbara Buldini, Jan Andreas Burger, Birgit Burkhardt, Ryan D. Cassaday, Giovanni Cazzaniga, Nadine Cerf-Bensussan, Ethel Cesarman, Mammen Chandy, Jennifer R. Chapman, Bjorn Chapuy, Xueyan Chen, Chee Leong Cheng, Carlos Chiattone, Nicholas Chiorazzi, Lucy B. Cook, Wendy A. Cooper, Gregory Philip Corboy, Andrew John Cowan, Immacolata Cozzolino, Ian A. Cree, Emanuele S. G. d'Amore, Andrew John Davies, Martina Deckert, Jan Delabie, Elizabeth G. Demicco, Vikram Deshpande, Arjan Diepstra, Daan Dierickx, Kieron Dunleavy, Barbara Eichhorst, Daisuke Ennishi, David C. Fajgenbaum, Pedro Farinha, Carlos Fernandez de Larrea, Kevin E. Fisher, Jude Fitzgibbon, Melina Flanagan, Jonathan Fromm, Juan F. Garcia, William Robert Geddie, Morie Gertz, Ajay Gopal, Satish Gopal, Patricia Theresa Greipp, Alejandro Gru, Ritu Gupta, Martin-Leo Hansmann, Konnie M. Hebeda, Klaus Herfarth, Marco Herling, Olivier Hermine, Khe Hoang-Xuan, Jennelle Hodge, Shimin Hu, Yuhua Huang, Yin Pun Hung, Stephen Hunger, Hiroto Inaba, Hiroshi Inagaki, Javeed Iqbal, Kenji Ishitsuka, Noriko Iwaki, Keiji Iwatsuki, Nitin Jain, Yoon Kyung Jeon, Marshall Kadin, Sachiko Kaji, Aanchal Kakkar, Anastasios Karadimitris, Keisuke Kataoka, Seiichi Kato, Marie Jose Kersten, Rhett P. Ketterling, Ji Eun Kim, Christian P. Kratz, Robert Kridel, Sigurdur Kristinsson, Ralf Kuppers, Isinsu Kuzu, Yok-Lam, Ann Lacasce, Laurence Lamant-Rochaix, Thierry Lamy, Ola Landgren, Siddhartha Laskar, William Bradlyn Laskin, Georg Lenz, Shaoying Li, Gan Di Li, Pei Lin, Franco Locatelli, Robert Brian Lorsbach, Izidore Lossos, Thomas P. Jr Loughran, William R. Macon, Joseph J. Maleszewski, Pankaj Malhotra, Teresa Marafioti, Dai Maruyama, Alexander Marx, Sam M. Mbulaiteye, Veronique Meignin, Ester Mejstrikova, Pamela Michelow, Markku Miettinen, Rodney R. Miles, Hiroaki Miyoshi, Thierry Jo Molina, Manuela Mollejo, Shuji Momose, Tetsuya Mori, William G. Morice, Bertrand Nadel, Hirokazu Nagai, Motoo Nagane, Reena Nair, Naoya Nakamura, Atsuko Nakazawa, Samih Nasr, Andrew Gordon Nicholson, Alina Nicolae, Robert Shigeo Ohgami, Naoki Oishi, Timothy S. Olson, Nicolas Ortonne, Bruno Paiva, Qiang Pan-Hammarstrom, Mayur Parihar, Marco Paulli, Andrea Petersen, Jennifer Picarsic, Alessandro Pileri, Nicola Pimpinelli, Jose A. Plaza, Karen R. Rabin, Markus Raderer, Kanti Rai, Ulla Randen, Huilan Rao, Alistair Robson, Rosemary Rochford, Richard Rosenquist, Davide Rossi, Esther D. Rossi, Simon Rule, Grzegorz Rymkiewicz, Elena Sabattini, Vaskar Saha, Mamiko Sakata-Yanagimoto, Christian A. Sander, J. Martin Sangueza, Omar P. Sangueza, Marco Santucci, Yasuharu Sato, Akira Satou, Kristian Theo Schafernak, Fernando Schmitt, Gianpietro Semenzato, Manju Sengar, Tait Shanafelt, Kazuyuki Shimada, Graham W. Slack, Susan Slager, Riccardo Soffietti, David A. Solomon, Kostas Stamatopoulos, Christian Steidl, Stephan Stilgenbauer, Narittee Sukswai, Kengo Takeuchi, Giovanni Tallini, Junichi Tamaru, Soo-Yong Tan, Prashant Tembhare, Enrico Tiacci, Yoshiki Tokura, Olivier Tournilhac, Steven Treon, Lorenz Truemper, Kunihiro Tsukasaki, Frits van Rhee, Abraham Varghese, Maarten H. Vermeer, Philippe Vielh, Brian Walker, Michael Wang, Huan-You Wang, Zhe Wang, Takashi Watanabe, Oliver Weigert, David Wein-Stock, Sean J. Whittaker, Rein Willemze, Wilhelm Woessmann, Catherine J. Wu, Motoko Yamaguchi, Hidetaka Yamamoto, Daisuke Yamashita, Shenmiao Yang, David T. Yang, Takahiko Yasuda, Wei-Hua Yin, Yoh Zen, Sha Zhao, Wei-Li Zhao

LEUKEMIA (2023)

Article Immunology

Gluten induces rapid reprogramming of natural memory alpha beta and gamma delta intraepithelial T cells to induce cytotoxicity in celiac disease

Adam Kornberg, Theo Botella, Christine S. S. Moon, Samhita Rao, Jared Gelbs, Liang Cheng, Jonathan Miller, Alyssa M. M. Bacarella, Javier A. A. Garcia-Vilas, Justin Vargas, Xuechen Yu, Izabela Krupska, Erin Bush, Reuben Garcia-Carrasquillo, Benjamin Lebwohl, Suneeta Krishnareddy, Suzanne Lewis, Peter H. R. Green, Govind Bhagat, Kelley S. S. Yan, Arnold Han

Summary: Celiac disease (CD) is an autoimmune disease characterized by intestinal inflammation triggered by dietary gluten. This study conducted single-cell analysis of T cells in the intestine and peripheral blood of CD patients in different disease states. The results showed that CD was associated with activated intestinal T cells, including follicular T helper cells, regulatory T cells, and natural killer cell receptor-expressing T cells. After gluten ingestion, cytotoxic T cells in CD were mobilized along with gluten-specific CD4(+) T cells. These findings suggest a rapid response of cytotoxic T cells in CD after gluten exposure.

SCIENCE IMMUNOLOGY (2023)

Meeting Abstract Medicine, Research & Experimental

Indeterminate Cell Histiocytosis is Clinically and Genetically Heterogenous Disease and Highly Associated with Other Hematopoietic Neoplasms

Neval Ozkaya, Sarah Melloul Benizri, Laszlo Karai, Sylvie Fraitag, Stefania Pittaluga, Maxime Battistella, Svetlana Pack, Liqiang Xi, Anne Moreau, Zofia Helias-Rodzewicz, Ina Lee, Jean Donadieu, Julien Haroche, Mark Raffeld, Elaine Jaffe, Jean-Francois Emile

LABORATORY INVESTIGATION (2023)

Letter Dermatology

CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas

[Anonymous]

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)

No Data Available